The overall objectives of this study were to characterize the presence of nutrients and emerging wastewater contaminants (pharmaceuticals, personal care products and antibiotic resistent genes) in the Grand Marais system and to evaluate the effectiveness of treatment wetlands in removal…
This paper aims to address the issue of the performance optimisation of pharmaceutical treatment in wastewater by ferrate (VI). The dose of ferrate, test water pHs and the physical and chemical properties of pharmaceuticals and their influece on the overall…
The objective of the guidance is to enable consistent quantification of the GHG inventory of pharmaceutical products and medical devices. It is relevant for all pharmaceutical products and medical devices manufactured and administered in any country. To address this variability…
This report provides an overview of the current knowledge, policy activities and future needs regarding human pharmaceuticals in the aquatic environment in Sweden and internationally. The report explains the research programme developed by Mistrapharma from 2008 to 2011, which focused…
This paper reports on the use of yeast and amylase as active agents for effluent bioremediation. The addition of yeast or amylase increased the breakdown of the organic matter present in a pharmaceutical effluent by microorganisms therefore aiding remediation. Yeast…
The anaerobic treatment system is a promising alternative for pharmaceutical wastewater treatment. This report is a case study of a laboratory investigation into the treatment of pharmaceutical wastewater containing the antibiotic Tylosin in an anaerobic reactor. Specifically, the research sought…